{"schemaVersion":1,"research":true,"symbol":"pru","name":"Prudential Financial","topic":"moat","path":"/stock/pru/moat","status":"published","version":4,"updatedAt":"2026-10-18T13:39:49.689Z","locked":false,"publicFairValue":false,"fairValue":null,"moat":{"verdict":"uncertain","summary":"Prudential's distribution relationships and PGIM capabilities are commercially established, but the supplied passages do not establish durable competitive superiority or realized pricing power. PGIM growth and improved consolidated earnings coexist with demonstrated erosion from misconduct and the Japanese sales suspension. These failures weaken the distribution thesis without establishing that the entire company lacks a moat.","advantages":[{"mechanism":"intangible_assets","claim":"Candidate advantage: proprietary distribution, customer relationships and investment capabilities. Management describes differentiated service and distribution; operating results demonstrate commercial relevance, but do not establish a defensible advantage over competitors.","durability":"Unestablished. Long-duration insurance obligations support continuing customer relationships, but neither superior persistency nor sustained pricing premiums are demonstrated. Planned PGIM cross-selling improvements remain potential.","risks":"The Japanese misconduct investigation and extended sales suspension demonstrate actual distribution impairment. Competition for sales personnel and distributors is intense; potential distributor renegotiation is a disclosed risk rather than a realized outcome.","invalidation":"The distribution thesis would weaken further if suspension continued beyond November 5, 2026, resumed sales failed to recover, or disclosed persistency and third-party client flows deteriorated. Evidence of sustained client retention, competitive investment performance and pricing outcomes through remediation would be needed to establish durability.","competitors":["Aflac Incorporated","Brighthouse Financial","CNO Financial Group","Globe Life","Lincoln National","MetLife, Inc."],"evidenceIds":["e1","e2","e3","e4","e5","e6"],"counterEvidenceIds":["e7","e8","e9","e10","e11"]}],"evidence":[{"id":"e1","sourceId":"filing-1","location":"Business: distribution advantage assertion and competition for personnel and channels","excerpt":"The ability to sell through multiple and complementary distribution channels is also a competitive advantage; however, competition for sales personnel, as well as access to third-party distribution channels, is intense."},{"id":"e2","sourceId":"filing-1","location":"Business: management's description of service-based international competition","excerpt":"In both of these markets, rather than competing primarily based on price, we generally compete on the basis of customer service, including our needs-based approach to selling, the quality and diversity of our distribution capabilities, and our financial strength."},{"id":"e3","sourceId":"filing-2","location":"MD&A, page 116: PGIM operating results","excerpt":"Operating Results The following table sets forth PGIM’s operating results for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 (in millions) Operating results(1): Revenues $ 1,107 $ 1,043 $ 2,147 $ 2,028 Expenses 813 814 1,663 1,643 Adjusted operating income 294 229 484 385 Equity in earnings of joint ventures and other operating entities, and earnings attributable to noncontrolling interests and redeemable noncontrolling interests 32 42 41 52 Other adjustments(2) (1) (1) (4) 27 Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities $ 325 $ 270 $ 521 $ 464 __________ (1)Certain of PGIM’s investment activities are based in currencies other than the USD and are therefore subject to foreign currency exchange rate risk."},{"id":"e4","sourceId":"filing-2","location":"MD&A, page 116: PGIM fees by affiliated and third-party source","excerpt":"116 Table of Contents The following table sets forth PGIM’s revenues, presented on a basis consistent with the table above under “—Operating Results,” by type: Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 (in millions) Revenues by type: Asset management fees by source: Institutional - Third Party $ 402 $ 387 $ 800 $ 774 Retail - Third Party 224 219 440 444 Affiliated(1) 238 219 471 435 Total asset management fees 864 825 1,711 1,653 Other related revenues by source: Incentive fees 25 24 38 34 Transaction fees 4 5 15 12 Seed and co-investments 34 28 46 34 Commercial mortgage(2) 31 25 60 40 Total other related revenues 94 82 159 120 Service, distribution and other revenues 149 136 277 255 Total revenues $ 1,107 $ 1,043 $ 2,147 $ 2,028 __________ (1)Includes revenues from the Company’s general account assets, as well as certain separate account assets of the Company’s insurance and retirement businesses managed by PGIM."},{"id":"e5","sourceId":"filing-1","location":"Business: pension risk transfer contractual obligations","excerpt":"Products The primary components of our material product types are described as follows: Institutional Retirement Strategies Group Annuities and Other Products • Pension risk transfers, which include non-participating group annuity insurance and reinsurance contracts issued to pension plan sponsors and intermediaries, under which we assume all investment and actuarial risk associated with a group of specified participants within a plan in return for a premium typically paid as a lump-sum at inception."},{"id":"e6","sourceId":"filing-3","location":"Compensation discussion: marketplace competitors used as performance peers","excerpt":"​ • Aflac Incorporated ​ • Brighthouse Financial ​ • CNO Financial Group ​ • Globe Life ​ ​ ​ • Lincoln National ​ • MetLife, Inc."},{"id":"e7","sourceId":"filing-2","location":"MD&A: internal investigation findings involving employee misconduct in Japan","excerpt":"(“Prudential of Japan”), a Japanese insurance subsidiary of the Company, reported the findings of its internal investigation into incidents of misconduct involving certain employees of Prudential of Japan."},{"id":"e8","sourceId":"filing-2","location":"MD&A: sales suspension extended through November 5, 2026","excerpt":"In April 2026, the Company announced the voluntary extension of the suspension of new sales for an additional 180 days through November 5, 2026."},{"id":"e9","sourceId":"filing-2","location":"MD&A: estimated suspension impact incurred through the first six months of 2026","excerpt":"The suspension of sales resulted in an estimated reduction of $235 million in International Businesses’ pre-tax adjusted operating income through the first six months of 2026."},{"id":"e10","sourceId":"filing-1","location":"Risk factors: potential distributor renegotiation","excerpt":"Consolidation of distributors and/or other industry changes may also increase the likelihood that distributors will try to renegotiate the terms of any existing selling agreements to terms less favorable to us."},{"id":"e11","sourceId":"filing-3","location":"Board strategy discussion: expected future cross-selling and margin improvements","excerpt":"We expect this new organizational structure, which includes a centralized distribution capability for institutional investors, will help double the percentage of clients engaging with two or more of our asset management businesses and drive additional margin growth over time."},{"id":"e12","sourceId":"filing-1","location":"Business: management's disclosed adjustment of products, prices and features","excerpt":"We periodically adjust product offerings, prices and features based on the market and our strategy, with a goal of achieving customer and enterprise value."},{"id":"e13","sourceId":"filing-1","location":"Regulation: premium-rate, policy-form and contractual-value restrictions","excerpt":"State insurance authorities possess broad administrative powers concerning all aspects of insurance business, including, among other things: (1) licensing for business operations; (2) agent licensing; (3) asset admittance to statutory surplus; (4) regulation of premium rates for specific products; (5) policy form approvals; (6) oversight of unfair trade and claims practices; (7) establishment of reserve requirements and solvency standards; (8) determination of maximum interest rates on life insurance policy loans and minimum accumulation or surrender values; (9) regulation of permissible investments by type, amount, and valuation; and (10) oversight of reinsurance transactions, including captive reinsurers."},{"id":"e14","sourceId":"filing-2","location":"Market risk benefits: contractual variable-annuity guarantees","excerpt":"The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals."},{"id":"e15","sourceId":"filing-3","location":"Non-GAAP reconciliation discussion: consolidated GAAP return on average equity","excerpt":"equity. Return on average equity (based on net income (loss)) was 11.7% and 9.6% for the years ended December 31, 2025 and December 31, 2024, respectively."},{"id":"e16","sourceId":"filing-2","location":"Note 18, page 89: consolidated earnings and basic and diluted weighted-average shares","excerpt":"EARNINGS PER SHARE A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the periods indicated is as follows: Three Months Ended June 30, 2026 2025 Income Weighted Average Shares Per Share Amount Income Weighted Average Shares Per Share Amount (in millions, except per share amounts) Basic earnings per share Net income (loss) $ 1,036 $ 566 Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests 51 33 Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards 12 6 Net income (loss) attributable to Prudential Financial available to holders of Common Stock $ 973 346.4 $ 2.81 $ 527 353.1 $ 1.49 Effect of dilutive securities and compensation programs Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic $ 12 $ 6 Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted 12 6 Stock options 0.0 0.1 Deferred and long-term compensation programs 1.7 1.7 Diluted earnings per share Net income (loss) attributable to Prudential Financial available to holders of Common Stock $ 973 348.1 $ 2.80 $ 527 354.9 $ 1.48 Six Months Ended June 30, 2026 2025 Income Weighted Average Shares Per Share Amount Income Weighted Average Shares Per Share Amount (in millions, except per share amounts) Basic earnings per share Net income (loss) $ 1,642 $ 1,308 Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests 60 68 Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards 21 16 Net income (loss) attributable to Prudential Financial available to holders of Common Stock $ 1,561 347.0 $ 4.50 $ 1,224 353.7 $ 3.46 Effect of dilutive securities and compensation programs Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic $ 21 $ 16 Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted 21 16 Stock options 0.1 0.1 Deferred and long-term compensation programs 1.7 1.7 Diluted earnings per share Net income (loss) attributable to Prudential Financial available to holders of Common Stock $ 1,561 348.8 $ 4.48 $ 1,224 355.5 $ 3.44 89 Table of Contents PRUDENTIAL FINANCIAL, INC."},{"id":"e17","sourceId":"filing-2","location":"Part II, Item 2: actual second-quarter 2026 repurchases and remaining authorization","excerpt":"ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (c) The following table provides information about purchases by the Company during the three months ended June 30, 2026, of its Common Stock: Period Total Number of Shares Purchased(1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Program(2) Approximate Dollar Value of Shares that May Yet Be Purchased under the Program(2) April 1, 2026 through April 30, 2026 861,126 $ 97.56 853,910 May 1, 2026 through May 31, 2026 823,270 $ 101.43 821,255 June 1, 2026 through June 30, 2026 788,002 $ 106.16 785,669 Total 2,472,398 2,460,834 $ 500,000,000 __________ (1)Includes shares of Common Stock withheld from participants for income tax withholding purposes whose shares of restricted stock units vested during the period."},{"id":"e18","sourceId":"filing-1","location":"Liquidity and capital resources: statutory limitations on subsidiary distributions","excerpt":"Our insurance companies are subject to limitations on the payment of dividends and other transfers of funds to Prudential Financial and other affiliates under applicable insurance law and regulation."},{"id":"e19","sourceId":"filing-3","location":"Compensation highlights: actual annual incentive awards","excerpt":"​ • Pay for Performance. Each of our NEOs received an annual incentive award of 106% of his or her target, consistent with the Company performance factor of 1.060."},{"id":"e20","sourceId":"filing-3","location":"Compensation highlights: actual 2023–2025 performance-share delivery","excerpt":"The Performance ​ Shares component of our 2023-2025 Long-Term Incentive Program delivered less than the target number of shares (88.3%)."},{"id":"e21","sourceId":"filing-1","location":"Stock compensation note: adopted performance-award modifications","excerpt":"These modifications 1) mitigate the impact of outsized interest rate volatility, both positive and negative, as it relates to achieving adjusted book value per share growth goals, and 2) reduce certain book value per share goals and maximum payout opportunities."},{"id":"e22","sourceId":"filing-1","location":"Stock compensation note: additional shares resulting from award modifications","excerpt":"The impact from these modifications increased shares to be delivered to 161 employees across all three performance plans by a total of approximately 600,000 shares."},{"id":"e23","sourceId":"filing-1","location":"Stock compensation note: incremental compensation cost from award modifications","excerpt":"In addition, total compensation costs resulting from these modifications increased by approximately $62 million."},{"id":"e24","sourceId":"filing-3","location":"Compensation policies: adopted clawback coverage and triggers","excerpt":"In accordance with SEC requirements and related NYSE listing standards, we maintain a clawback policy that covers all executive officers (including the NEOs), applies to all incentive-based compensation (including stock options and other equity awards) paid to or in respect of an executive officer, and includes separate triggers for financial restatements and improper conduct (including failure to report)."},{"id":"e25","sourceId":"filing-3","location":"Corporate governance: independence of key board committees","excerpt":"Each member of the Audit, Compensation and Human Capital, and Corporate Governance and Business Ethics Committees has been determined by the Board to be independent for purposes of the NYSE Corporate Governance listing standards."},{"id":"e26","sourceId":"filing-3","location":"Leadership disclosures: combination of chairman and CEO roles","excerpt":"​ • Mr. Sullivan became Chairman, in addition to CEO, on March 10, 2026."},{"id":"e27","sourceId":"filing-2","location":"Derivatives note: compliance with contractual collateral requirements","excerpt":"All derivatives have been appropriately collateralized by the Company or the counterparty in accordance with the terms of the derivative agreements."},{"id":"e28","sourceId":"filing-1","location":"Liquidity: management's assessment of insurance operating cash flows","excerpt":"In each of our major insurance subsidiaries, we believe that the cash flows from operations are adequate to satisfy current liquidity requirements."},{"id":"e29","sourceId":"filing-1","location":"Risk factors: dependence on wholesale funding markets","excerpt":"•Wholesale funding: The Company depends upon the financial markets for funding (such as through the issuance of commercial paper, securities lending and repurchase arrangements and other forms of borrowings in the capital markets)."},{"id":"e30","sourceId":"filing-2","location":"MD&A: USD-denominated assets supporting USD-denominated Japanese liabilities","excerpt":"Separate from this program, our Japanese operations also have $92.3 billion and $90.0 billion as of June 30, 2026 and December 31, 2025, respectively, of USD-denominated assets supporting USD-denominated liabilities related to USD-denominated products."},{"id":"e31","sourceId":"filing-2","location":"MD&A, page 168: mortgage and agricultural loan collateral and debt-service coverage","excerpt":"The following tables set forth the gross carrying value of our commercial mortgage and agricultural property loans by loan-to-value and debt service coverage ratios, as of the dates indicated: June 30, 2026 Debt Service Coverage Ratio > 1.2x 1.0x to < 1.2x < 1.0x Total Commercial Mortgage and Agricultural Property Loans Loan-to-Value Ratio (in millions) 0%-59.99% $ 27,769 $ 1,472 $ 654 $ 29,895 60%-69.99% 13,388 444 275 14,107 70%-79.99% 4,696 420 151 5,267 80% or greater 3,001 265 1,436 4,702 Total commercial mortgage and agricultural property loans $ 48,854 $ 2,601 $ 2,516 $ 53,971 December 31, 2025 Debt Service Coverage Ratio > 1.2x 1.0x to < 1.2x < 1.0x Total Commercial Mortgage and Agricultural Property Loans Loan-to-Value Ratio (in millions) 0%-59.99% $ 27,975 $ 798 $ 520 $ 29,293 60%-69.99% 13,706 956 213 14,875 70%-79.99% 4,810 270 173 5,253 80% or greater 2,942 312 1,523 4,777 Total commercial mortgage and agricultural property loans $ 49,433 $ 2,336 $ 2,429 $ 54,198 168 Table of Contents The following table sets forth the breakdown of our commercial mortgage and agricultural property loans by year of origination, as of the date indicated: June 30, 2026 Gross Carrying Value % of Total Year of Origination ($ in millions) 2026 $ 2,551 4.7 % 2025 6,822 12.6 2024 7,237 13.4 2023 5,247 9.7 2022 3,822 7.1 2021 6,272 11.6 2020 2,837 5.3 2019 & Prior 18,981 35.2 Revolving Loans 202 0.4 Total commercial mortgage and agricultural property loans $ 53,971 100.0 % Residential Mortgage Loans Residential mortgage loans primarily include fixed-rate, amortizing mortgage loans on rental properties owned by borrowers with FICO scores typically considered prime or above."},{"id":"e32","sourceId":"filing-2","location":"Market risk benefits: unfavorable actuarial assumption updates in 2026 and 2025","excerpt":"In both 2026 and 2025, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions."},{"id":"e33","sourceId":"filing-2","location":"Investment risk: growth in loans against unstabilized properties","excerpt":"Our commercial mortgage and agricultural property loan portfolio included $3.6 billion and $2.7 billion of such loans as of June 30, 2026 and December 31, 2025, respectively."},{"id":"e34","sourceId":"filing-2","location":"Investment management: separate investment pricing and authorization processes","excerpt":"We have separate pricing and authorization processes to establish “checks and balances” for new investments."},{"id":"e35","sourceId":"filing-2","location":"PGIM business updates: agreement to acquire remaining Deerpath interest","excerpt":"Results of Operations by Segment PGIM Business Updates •In July 2026, the Company entered into an agreement to acquire the remaining 25% interest in Deerpath Capital Management, LP (“Deerpath”), bringing the Company’s ownership to 100% after acquiring a 75% majority stake in December 2023."},{"id":"e36","sourceId":"filing-1","location":"Operating measures: insurance revenue reflects renewal persistency, investment income and current sales","excerpt":"GAAP. Annualized new business premiums measure the current sales performance of the business, while revenues primarily reflect the renewal persistency of policies written in prior years and net investment income, in addition to current sales."},{"id":"e37","sourceId":"filing-1","location":"MD&A, page 67: International Businesses operating results for 2023–2025","excerpt":"The following table sets forth the International Businesses’ operating results for the periods indicated: Year Ended December 31, 2025 2024 2023 (in millions) Operating results: Revenues $ 18,148 $ 17,925 $ 18,682 Benefits and expenses 14,901 14,819 15,499 Adjusted operating income 3,247 3,106 3,183 Realized investment gains (losses), net, and related charges and adjustments 123 (911) 93 Change in value of market risk benefits, net of related hedging gains (losses) 18 17 14 Market experience updates 98 89 (46) Equity in earnings of joint ventures and other operating entities and earnings attributable to noncontrolling interests (157) (116) (76) Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities $ 3,329 $ 2,185 $ 3,168 2025 to 2024 Annual Comparison Adjusted operating income increased $141 million, including an unfavorable comparative net impact of $14 million from currency fluctuations."},{"id":"e38","sourceId":"filing-2","location":"Investment risk: relative risk of unstabilized property collateral","excerpt":"All else being equal, these loans are inherently riskier than those collateralized by properties that have already stabilized."},{"id":"e39","sourceId":"filing-2","location":"MD&A: forecast suspension effects for 2026 and 2027","excerpt":"We estimate that the suspension of new sales as extended will result in a reduction of pre-tax adjusted operating income in the range of $525 to $575 million for 2026, inclusive of the six month impact above, and in the range of $400 to $450 million for 2027, reflecting remediation costs associated with sustaining the business, one-time and other operating costs, and lower earnings attributable to the gradual ramp-up of new sales after sales resume."}],"changes":["Retains the previous uncertain moat verdict; the evidence still does not establish either durable superiority or company-wide interchangeability.","Adds criterion-level management, pricing and insurance financial assessments. The proxy supplies actual incentive outcomes and governance policies, while current filings supply earnings, repurchases and investment-risk evidence.","Distinguishes the estimated $235 million suspension impact through June 2026 from forecast full-year and 2027 effects."],"limitations":["Only supplied passages were used. Dates are filing dates, retaining dateKind=filed; no retrieval date is treated as publication.","Named competitors are explicitly identified marketplace performance peers. Their product-level pricing, retention and investment results are absent; international and PGIM competitor coverage remains unestablished.","Distribution differentiation, investment access and future cross-selling benefits are issuer assertions or expectations, not demonstrated durable competitive superiority.","No realized premium-rate or fee-rate series, price-volume decomposition, explicit persistency rates or client renewal statistics are supplied.","Current solvency ratios with exact denominators and applicable requirements, comprehensive available liquidity, and total shareholder dividend amounts are missing. Capital sufficiency and complete distribution coverage cannot be established.","Executive ownership amounts and complete compensation costs are absent. Actual award outcomes, adopted modifications and clawback policies permit a limited alignment assessment.","All numerical financial grades rely on filings dated within 550 days of October 18, 2026. Older filings do not establish current financial sufficiency.","Financial and margin results are assessed as operating evidence, not as proof of a moat or pricing power."],"qualityAssessments":[{"category":"moat","checks":[{"criterion":"structural_advantage","grade":null,"rationale":"Distribution and PGIM capabilities are established, but comparative barriers and superior economics attributable to a defensible mechanism are not demonstrated.","evidenceIds":["e1","e2","e3"]},{"criterion":"durability","grade":null,"rationale":"Long-duration obligations do not establish a durable competitive advantage; planned cross-selling gains remain prospective.","evidenceIds":["e5","e11"]},{"criterion":"customer_dependency","grade":null,"rationale":"Contractual relationships exist, but customer switching penalties, superior persistency and dependence on Prudential-specific capabilities are not established.","evidenceIds":["e5","e36"]},{"criterion":"erosion_resilience","grade":null,"rationale":"The Japanese suspension demonstrates erosion, while PGIM growth provides counterbalancing operating evidence. Resilience of a company-wide moat remains unestablished.","evidenceIds":["e3","e8","e9"]}]},{"category":"pricing_power","checks":[{"criterion":"realized_pricing","grade":null,"rationale":"Management reports adjusting prices, but fee and revenue growth do not isolate realized rate changes or pricing relative to risk.","evidenceIds":["e12","e4"]},{"criterion":"retention","grade":2,"rationale":"Indirect evidence is mixed: continuing insurance revenue and third-party institutional fees support ongoing demand, while retail third-party fees declined slightly. Market values, investment income and new business confound retention; no retention rate is inferred.","evidenceIds":["e4","e36","e37"]},{"criterion":"margin_resilience","grade":2,"rationale":"PGIM's first-half revenue and adjusted operating income increased with much smaller expense growth. The estimated incurred Japanese suspension cost demonstrates meaningful vulnerability elsewhere; segment results do not prove pricing-driven resilience.","evidenceIds":["e3","e9"]},{"criterion":"contractual_freedom","grade":2,"rationale":"Prudential adjusts product prices and features, but regulatory premium-rate powers and existing annuity guarantees constrain discretion. Broad freedom to reprice in-force obligations is not established.","evidenceIds":["e12","e13","e14"]}]},{"category":"strong_management","checks":[{"criterion":"capital_discipline","grade":2,"rationale":"Consolidated GAAP ROE improved and repurchases accompanied lower weighted-average shares. Missing solvency headroom, full distributions and transaction returns limit confidence that capital deployment optimally balanced returns and buffers.","evidenceIds":["e15","e16","e17","e18"]},{"criterion":"incentive_alignment","grade":2,"rationale":"Actual performance-share delivery below target and adopted clawbacks support alignment. Earlier award modifications increased share delivery and compensation costs, weakening strict pay-for-performance interpretation. Executive ownership is not quantified.","evidenceIds":["e19","e20","e21","e22","e23","e24"]},{"criterion":"execution","grade":2,"rationale":"Observed PGIM growth and improved consolidated earnings support execution, but employee misconduct and the extended Japanese suspension demonstrate a material operational failure. This assessment uses operating outcomes, not management reputation.","evidenceIds":["e3","e16","e7","e8","e9"]},{"criterion":"governance","grade":1,"rationale":"Independent key committees and an adopted clawback policy provide safeguards, but realized misconduct and prolonged disruption demonstrate fragile oversight effectiveness. The chairman and CEO roles were combined; remediation effectiveness is not yet demonstrated.","evidenceIds":["e25","e24","e26","e7","e8"]}]}],"financialAssessments":[{"category":"financial_strength","checks":[{"criterion":"capital_adequacy","grade":null,"rationale":"The passages describe solvency regulation but omit current insurer capital ratios, exact denominators and applicable requirements. Earnings and repurchases cannot substitute for demonstrated solvency headroom.","evidenceIds":[]},{"criterion":"liquidity_funding","grade":2,"rationale":"Current contractual derivative collateralization and management's operating-cash-flow adequacy assessment support a mixed assessment. Wholesale funding dependence remains relevant; unrestricted liquidity, maturities and stress coverage are not quantified. No funding shortfall is demonstrated.","evidenceIds":["e27","e28","e29"]},{"criterion":"asset_liability_risk","grade":2,"rationale":"Currency-matched Japanese assets and predominantly stronger loan debt-service coverage support risk management. Loans with debt-service coverage below 1.0x, growing unstabilized-property exposure and unfavorable policyholder-behavior assumption updates offset this. Duration matching and aggregate reinsurance recoverability remain incomplete.","evidenceIds":["e30","e31","e32","e33","e38"]},{"criterion":"earnings_resilience","grade":2,"rationale":"First-half 2026 consolidated net income increased to $1.642 billion from $1.308 billion despite the Japanese suspension, and PGIM improved. Incurred suspension costs and unfavorable actuarial updates temper resilience; the disclosed period does not demonstrate exceptional performance through a full stress cycle.","evidenceIds":["e16","e3","e9","e32"]}]},{"category":"capital_allocation","checks":[{"criterion":"capital_efficiency","grade":2,"rationale":"Consolidated GAAP return on average equity rose from 9.6% in 2024 to 11.7% in 2025, with equity defined as average total Prudential Financial equity. This demonstrates improvement, but does not establish exceptional capital productivity or superior insurer-level statutory returns.","evidenceIds":["e15"]},{"criterion":"distributions_and_buffers","grade":2,"rationale":"Actual second-quarter repurchases and positive first-half consolidated earnings support distributions. The remaining authorization indicates spending discretion, and subsidiary transfers face statutory restrictions. Missing total dividends and solvency headroom prevent a strong buffer assessment.","evidenceIds":["e17","e16","e18"]},{"criterion":"dilution_and_cost","grade":2,"rationale":"First-half basic weighted-average shares fell from 353.7 million to 347.0 million, with diluted shares also declining. Compensation remains dilutive, and adopted award modifications added approximately 600,000 shares and $62 million of costs. Total current compensation and financing costs are not supplied.","evidenceIds":["e16","e17","e22","e23"]},{"criterion":"investment_discipline","grade":2,"rationale":"Separate investment authorization controls and disclosed loan collateral coverage support discipline. Rising exposure to unstabilized properties adds risk. The Deerpath purchase is an agreement, with neither purchase economics nor subsequent returns supplied, so acquisition success is unproven.","evidenceIds":["e34","e31","e33","e38","e35"]}]}],"qualityPolicy":"quality-scores-2","sourcePolicy":"issuer-evidence-4","financialAssessmentPolicy":"financial-industry-1","financialSector":"insurance","basisHash":"e1b8eb7c54ff7513714a4e28d516b6942a5e1110775acd5591cb2a5e40dbf4fb","updatedAt":"2026-10-18T13:39:49.689Z","sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777426000048/pru-20251231.htm","publishedAt":"2026-02-12","sha256":"c70351649a0d2393d8e0e6b0cecc4bd6d929bc5f0c9203a58260c6f93cb64ab8","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777426000176/pru-20260630.htm","publishedAt":"2026-08-05","sha256":"a534e1f29cd8b43f0cda9ede4a630648b45aa9fdb67dab5206ab94cb874df99a","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/1137774/000110465926035162/tm2524217-6_def14a.htm","publishedAt":"2026-03-26","sha256":"e9ae9fe1ea84a0b5fa3f3eb1ec56c29d3de23578cee7add40e0d08bff11dc300","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777425000044/pru-20241231.htm","publishedAt":"2025-02-13","sha256":"05aeee25227ab06975327fc838a56e5d51086bcb9a759af8737c690e568794f3","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777424000045/pru-20231231.htm","publishedAt":"2024-02-21","sha256":"b5dcec16f25d46a8506510a109e221e54429ce63d4982865f715d9f15286dbde","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777426000095/pru-20260331.htm","publishedAt":"2026-05-06","sha256":"10b57a5e2945c437f34837704ec0c95c5e103cdc151e45c0b496699defc37094","dateKind":"filed"}],"model":"gpt-6.1-sol","providerId":"codex:af40770703a41a2ed1c12435c12d952a81d9f42616d0e31710d2c19798d8c9ac","usage":{"input_tokens":91066,"cached_input_tokens":21120,"cache_write_input_tokens":0,"output_tokens":4644,"reasoning_output_tokens":162},"basisSupplement":{"previousHash":"61a31fa398d0f7e458c218bfdda57bb40bee1a230b91cd89199dbe47ea04411b","checkedAt":"2026-10-18T16:49:32.080Z","rule":"dated historical and missing inputs only; accepted observations and research date retained"}},"signals":[{"period":"2021","end":"2021-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"peg":"Prior-year TTM earnings per diluted share is zero or negative; a growth-adjusted multiple is undefined.","pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2022","end":"2022-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"pe":"Trailing earnings is zero or negative, so this ratio is undefined.","peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2023","end":"2023-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"peg":"Prior-year TTM earnings per diluted share is zero or negative; a growth-adjusted multiple is undefined.","pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2024","end":"2024-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2025","end":"2025-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}}],"sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777426000048/pru-20251231.htm","publishedAt":"2026-02-12","sha256":"c70351649a0d2393d8e0e6b0cecc4bd6d929bc5f0c9203a58260c6f93cb64ab8","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777426000176/pru-20260630.htm","publishedAt":"2026-08-05","sha256":"a534e1f29cd8b43f0cda9ede4a630648b45aa9fdb67dab5206ab94cb874df99a","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/1137774/000110465926035162/tm2524217-6_def14a.htm","publishedAt":"2026-03-26","sha256":"e9ae9fe1ea84a0b5fa3f3eb1ec56c29d3de23578cee7add40e0d08bff11dc300","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777425000044/pru-20241231.htm","publishedAt":"2025-02-13","sha256":"05aeee25227ab06975327fc838a56e5d51086bcb9a759af8737c690e568794f3","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777424000045/pru-20231231.htm","publishedAt":"2024-02-21","sha256":"b5dcec16f25d46a8506510a109e221e54429ce63d4982865f715d9f15286dbde","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/1137774/000113777426000095/pru-20260331.htm","publishedAt":"2026-05-06","sha256":"10b57a5e2945c437f34837704ec0c95c5e103cdc151e45c0b496699defc37094","dateKind":"filed"}],"history":[{"version":4,"updatedAt":"2026-10-18T16:49:32.080Z","verdict":"uncertain","value":null},{"version":3,"updatedAt":"2026-10-18T16:35:43.872Z","verdict":"uncertain","value":null},{"version":2,"updatedAt":"2026-10-18T02:27:49.793Z","verdict":"uncertain","value":null},{"version":1,"updatedAt":"2026-10-18T02:18:02.026Z","verdict":null,"value":null}],"hasRequested":false,"requestStatus":"completed","researchIssue":null,"archivedMoat":null,"scope":"supported_catalog"}